Oral Oncology

Papers
(The TQCC of Oral Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Rare mandibular metastasis of Ewing sarcoma presenting as an endodontic infection78
Comment on “Circulating miRNAs as diagnostic biomarkers in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC)”57
Commentary on, “Optimization of methylation capture sequencing workflow in formalin fixed tissue from oral squamous cell carcinoma patients”54
Commentary on, “Transoral endoscopic thyroidectomy vestibular approach for pT1b papillary thyroid carcinoma: Surgical and oncological outcomes.”51
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”51
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma42
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis40
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma37
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review35
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?33
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection32
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment32
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review32
Myxoid variant of extramammary myofibroblastoma affecting the buccal mucosa: An extremely rare oral lesion and literature review32
Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990–202131
Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study31
Overestimated risk of transformation in oral lichen planus30
Artificial intelligence for oral cancer diagnosis: What are the possibilities?29
Turning tumor microenvironmental foes to friends: A new opportunity for thyroid cancer therapy and redifferentiation29
DNA Methylation Mediated Epigenetic Silencing of PD-1 and PD-L1: Therapeutic Implications in Oral Cancer29
Corrigendum to “Epigenetics: Promising journey so far but ways to go in head neck cancer” [Oral Oncol. 135 (2022) 106194]29
Radiation-induced sarcomas of the craniofacial region: A systematic review28
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma28
Letter to the editor, “Letter to the editor, “Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.”27
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions27
Division versus de-epithelialization of fibula osteocutaneous flap for composite oromandibular defects: A propensity score-matched analysis27
Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”27
What does margin mean in laryngeal surgery?26
Comment on: “Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: A pilot randomized controlled trial”25
Comment on: Predictors of recurrence, and the impact of adjuvant radiation therapy on survival in early stage (pT1–2, N0) oral cavity squamous cell carcinoma: A matched pair analysis25
Illustrating potential actionable drug targets of head and neck tumors based on comprehensive genomic landscape of 386 samples25
The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD)24
Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study24
Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study24
Required time for pre-oncological dental management – A rapid review of the literature24
Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients24
Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes23
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis23
Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study22
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]22
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis22
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus–related malignancies22
Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer21
Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database21
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study21
Clinicopathological factors associated with progression of oral submucous fibrosis: A population-based retrospective study21
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients21
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharynge20
Squamous odontogenic tumor like proliferations in dentigerous cyst- a great mimicker20
Editorial Board/Aims & Scope20
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies20
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection20
Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model20
Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 220
Salvage surgery in nasopharyngeal Cancer: Unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors19
“Time is not to be wasted”19
Tumor subtype classification tool for HPV-associated head and neck cancers19
Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial19
Comparison between adult comorbidity evaluation-27 and Charlson Comorbidity Index in head and neck oncology19
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis19
Commentary on, “Margin analysis of radical tonsillectomy specimens following transoral robotic surgery”19
Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis19
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma19
P28 Head and neck cancer cells differentiate resembling their tissue of origin19
Commentary on: From mutation maps to clinical impact: Unraveling OSCC genomics in a japanese nationwide cohort18
Corrigendum to “Prognostic factors in surgically treated malignant salivary gland tumors” [Oral Oncol. 144 (2023) 106484]18
Deep learning for the automatic detection and segmentation of parotid gland tumors on MRI18
BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients18
Comment on “The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis”18
Completion thyroidectomy for intermediate risk factors after thyroid lobectomy17
Comment on “The association between health-related quality of life and five-year overall survival among head and neck cancer patients: A prospective cohort study”17
Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials17
FLASH radiotherapy in head and neck cancer: Myth or reality?17
Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma17
Papillary thyroid cancer in black thyroid: A case report17
Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions17
“In response to “Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia”17
Corrigendum to “Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas”. [Oral Oncol. 163 (2025) 107207]17
Letter to the Editor: Prognostic value of age-adjusted comorbidity scoring in OSCC - a step toward personalized oncology17
Re-evaluating Lymph Node Yield, Lymph Node Ratio, and the number of metastatic nodes as prognostic factors in oral cavity squamous cell carcinoma17
Intraosseous rhabdomyosarcoma of the maxilla with TFCP2 fusion: A rare aggressive subtype with predilection for the gnathic bones17
Letter to Editor on, “De-escalated surgery following neoadjuvant chemoimmunotherapy for locally advanced oral squamous cell carcinoma: A retrospective cohort study”17
P25 The role of ultrasound elastography for clinical neck staging in HPV-related oropharyngeal cancer16
Innovative applications of hybrid operating room in otolaryngology: A pilot study16
Pain management with popliteal block for fibular graft harvesting in head and neck reconstruction; a randomised double-blind placebo-controlled study16
P35 Spatial proteomics and metabolomics investigations in head & neck cancers16
Comment on: Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions16
Impact of HPV status on immune responses in head and neck squamous cell carcinoma16
Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma16
O1.3 Awareness of HPV-associated oropharyngeal cancer among the general population and general practitioners in the Netherlands: Cross-sectional study16
Response to the comment on “The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations”16
Editorial Board/Aims & Scope16
Osteoblastoma of the maxilla: A case report and review of the literature16
ChatGPT: Empowering dentistry with future possibilities16
Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma16
Editorial Board16
Selective autophagy as a potential therapeutic target for oral cancer16
P29 Comparison of selected clinical factors and treatment results according to HPV status in patients with oropharyngeal cancer treated with radiotherapy alone or combined with chemotherapy16
Letter to the Editor: Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma15
Association between E-cigarette use and oral HPV-16 infection15
Tobacco induced epithelial dysplasia at minor salivary gland excretory duct and oral cancer15
Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancer15
Positive margins matter regardless of subsequent resection findings15
Refining prognosis and Personalizing Therapy: A Step Forward with Machine learning in HPV-Associated head and neck cancer15
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers15
Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?15
Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma15
Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity15
Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma15
Spindle cell squamous cell carcinoma of alveolus with heterologous mesenchymal differentiation and synchronous contralateral buccal squamous cell carcinoma in a background of oral submucous fibrosis: 15
Palliative care utilization among head and neck cancer patients: A population-based analysis15
Validity of functional patient-reported outcomes in head and neck oncology: A systematic review15
Clinical outcomes following observation, post-operative radiation therapy, or post-operative chemoradiation for HPV-associated oropharyngeal squamous cell carcinomas14
Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapy14
Comment on: Life following total laryngectomy: mixed-model analyses of longitudinal patient-reported outcomes in a prospective cohort14
Comment on, “Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes”14
CD271high cancer stem cells regulate macrophage polarization in head and neck squamous cell carcinoma14
Impact of HIV status on overall survival in head and neck cancers by anatomical site and stage: A multi-center cohort study14
The importance of early treatment of oral squamous cell carcinoma: Case report14
Critical appraisal of post-treatment monitoring of surgically treated oropharyngeal squamous cell carcinoma patients using human papillomavirus cell-free DNA: promising potential amid methodological c14
The case against lingual mucosectomy14
Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma14
CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy14
The integration of female physiological and social role factors in HRQOL research14
Elective neck dissection: Are we bound to outdated concepts?14
Is postoperative adjuvant therapy necessary for pT3N0 oral cavity squamous cell carcinoma?14
Exploring the potential of gemcitabine, capecitabine, and tislelizumab after anti-PD-1 treatment in nasopharyngeal carcinoma14
Photobiomodulation for the prevention of oral side effects secondary to head and neck cancer therapy: results of a randomised, single-blind clinical trial14
Could definitive radiotherapy be a treatment option for lymphoepithelial carcinoma of major salivary gland: Comparison of clinical outcomes of upfront surgery and upfront chemoradiotherapy14
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unre13
Comment on “Surgical, functional, and oncological outcomes of transoral robotic surgery for cT1-T3 supraglottic laryngeal cancers: A systematic review”13
Superficial angiomyxoma affecting the buccal mucosa: A detailed immunohistochemical study and literature review13
Confusion prevails in severe oral epithelial dysplasia with microinvasion versus microinvasive carcinoma13
Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma13
Late oral adverse effects of chemotherapy for hematological malignancies in children: A systematic review and meta-analysis of case-control studies13
Correspondence on “Global burdens of nasopharyngeal carcinoma in children and young adults: Trends and predictions to 2040”13
Letter to the editor, “Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral cancer”13
Risk factors and a risk assessment model for venous thromboembolism in head and neck cancer surgery13
Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening13
Unfamiliar case of metastatic myxoid leiomyosarcoma of mandible13
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer13
FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma13
Revolutionizing HPV-driven cancer surveillance: A commentary on the validation of the HPV-SEQ liquid biopsy platform13
Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma13
A rare case of extranodal Rosai Dorfman disease of zygoma13
Mitigating survival disparities in head and neck cancer: urgent need to reduce ED-based biopsy delays13
Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma12
The submandibular gland in neck dissection: A necessary casualty or a hapless victim?12
Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma12
Clinical value of entire-circumferential intraoperative frozen section analysis for the complete resection of superficial squamous cell carcinoma of the tongue12
Lymph node yield and ratio in the central compartment12
Head and neck radiotherapy leading to extensive late oral soft-tissue necrosis12
O3.3 Proximity ligation-based sequencing for mapping viral integration sites in human papillomavirus positive head and neck squamous cell carcinomas12
Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study12
Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck12
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)12
The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma12
Skeletal muscle mass at C3 is a strong predictor for skeletal muscle mass at L3 in sarcopenic and non-sarcopenic patients with head and neck cancer12
Extent of neck dissection in the N+ neck: Adjudicating a Conundrum!12
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma – “Need for incorporation of sub classification of pT4b lesions”12
Editorial Board12
Basal cell adenocarcinoma of the soft palate: A closer look for an exceedingly rare salivary gland tumor12
Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case12
Hemangiomatous adenomatoid odontogenic tumor of maxilla: A new variant?12
Two-stage surgery for the treatment of nonmelanoma skin cancer of the face: Change of surgical strategy during COVID-19 pandemic12
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer11
De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?11
Pain management following transoral robotic surgery for oropharyngeal squamous cell Carcinoma: A systematic review11
Thyroid volumes after intensity‐modulated radiotherapy as predictors of radiation‐induced hypothyroidism in nasopharyngeal carcinoma: A retrospective study11
Corrigendum to “Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer” [Oral Oncol. 51 (2015) 565–569]11
Toward comprehensive optimization of larynx-preserving strategies in MI-LSCC11
Are we ready to use ultrasounds in the clinical assessment of depth of invasion and tumor thickness in oral squamous cell carcinoma? Results from a systematic review, meta-analysis and trial sequentia11
Lichenoid infiltrate in oral submucous fibrosis: A new marker of malignant transformation11
Metformin and oral cancer11
Ferroptosis: An emerging therapeutic target for oral cancer11
Comment on: Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy11
Evaluating observer reliability and diagnostic accuracy of CT-LEFAT criteria for post-treatment head and neck lymphedema: A prospective blinded comparative analysis11
Corrigendum to “Flash radiotherapy-gateway to promised land or another mirage” [Oral Oncol. 139 (2023) 106342]11
When histology tells a different story: salivary duct carcinoma in disguise11
Mandibular swing approach: 25 years of experience at Istituto Nazionale Tumori of Milan11
Letter to the Editor: “Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell Carcinoma”11
Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?11
Commentary on “Predictive value of CXCL1+_FAP+ phenotype in CAFs for distant metastasis and its correlation with PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma patients”11
Tongue cancer in non-smoking and non-alcoholic mother and daughter11
Editorial Board11
Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study11
Letter to the editor “The use of 3D computer-aided design to optimize photoimmunotherapy catheter placement”11
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma11
Comment on “The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations”10
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area10
O3.2 Loss of LRP1B expression drives chemo and radiation resistance in HPV-positive head and neck cancer10
The impact of physician’s characteristics on decision-making in head and neck oncology: Results of a national survey10
Bispecific antibodies targeting tumor-associated metalloprotease and recruit NK cells – Multifunctional therapeutic approach against oral cancer10
Mammary analogue secretory carcinoma presenting as localized hematoma of the palate10
Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study10
Analysis of the effects of mandibular reconstruction based on microvascular free flaps after oncological resections in 21 patients, using 3D planning, surgical templates and individual implants10
Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer10
The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations10
Feasibility study of intensive intervention using novel trismus device during adjuvant radiation for head and neck cancer: RestorabiteTM10
Editorial Board/Aims & Scope10
Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice10
Role of neoadjuvant chemotherapy in head and neck cancer management: A case for exploring diverse treatment strategies for evaluating long-term efficacy10
Should sitting time be a treatment target in head and neck cancer patients receiving curative treatment?10
Merkel cell carcinoma – Time to consider personalized medicine and combinatorial therapeutic strategies10
Anti-epidermal growth factor receptor targeted therapy-associated ulcerations10
30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-10
Health-related quality-of-life assessment in patients with oropharyngeal cancer: A comparison of EQ-5D-5L and EORTC instruments10
Comment on: “The role of adjuvant radiotherapy in relation to tumor size for bone-invasive pT4aN0 oral squamous cell carcinoma-A retrospective observational matched cohort study”10
Telescreening as an alternate modality for early detection of oral cancer10
EpCAM and EGFR crosstalk in the development of resistance towards Cetuximab treatment in head and neck cancer10
E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma10
Perioral reconstruction by submental flap10
Corrigendum to “Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma” [Oral Oncol. 134 (2022) 106131]10
O1.2 Single cell RNA sequencing allows mapping of HPV transcripts in head and neck cancer epithelial cells10
The utility of ultrasonographic surveillance in management of a presumed branchial cleft cyst later confirmed HPV-associated oropharyngeal cancer10
Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 s10
Correlation between radiological, macroscopic and microscopic depth of invasion in oral squamous cell carcinoma: A prospective study using contrast-enhanced computed tomography10
Letter to the Editor: Impact of the COVID-19 pandemic on diagnosis and disease stage in HPV-positive oropharyngeal cancer: insights and future directions9
The state of virtual surgical planning in maxillary Reconstruction: A systematic review9
Prognostic factors in surgically treated malignant salivary gland tumors9
Comment on “Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients”9
Comment on: Salivary DNA methylation derived estimates of biological aging, cellular frequency, and protein expression as predictors of oral mucositis severity and survival in head and neck cancer pat9
Personalized intraoral devices in the era of high-technology head and neck radiotherapy: A resource to be explored9
Advancing precision prevention: enhancing the hypoxia–microbiota framework in oral potentially malignant disorders9
Advancing precision radiotherapy through AI/ML in appliance design and patient outcome prediction: a complement to the GUARD trial9
AI-driven histopathologic insights in HPV-positive head and neck squamous cell carcinomas9
Oncological outcomes of pathological extranodal extension (pENE) in oral squamous cell carcinoma (OSCC): A proposal to refine the current staging9
Commentary on, “Prevalence of oral human papillomavirus infection among adult men and women in Taiwan (PILLOT).”9
Letter to the editor, “The prognostic value of pretreatment 18F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma.”9
Scapula or Fibula?: Prospective data-driven decision criteria for flap selection in mandibular reconstruction planning9
Corrigendum to “Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer” [Oral On9
Lung cancer metastases to the oral cavity: Report of two cases and review of literature9
Prophylactic gastrostomy tube during chemoradiation for head and neck cancer decreases weight loss but increases rate of tube use beyond six months9
Young non-smokers with oral cancer: What are we missing and why?9
High expression of H2AX/γ-H2AX is associated with distinct biological pathway alterations and shorter survival in oropharyngeal squamous cell carcinoma9
Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma9
Commentary on “Predicting reactive Gastrostomy-Tube placement after head and neck free flap Reconstruction”9
Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy9
Establishing a role for the oral microbiome in infectious complications following major oral cavity cancer surgery9
Malignant odontogenic tumors. A report of a series of 30 cases and review of the literature9
Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR study9
Postoperative complications of neck dissection for head and neck squamous cell carcinoma: a systematic review and meta-analysis9
Commentary on, “Oncologic significance of the lateral margin in buccal cancer.”9
Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs8
Anteromedial thigh septocutaneous perforator flap as a first choice for head and neck reconstruction: A clinical algorithm based on perforator-pedicle relationship8
Predicting outcomes in head and neck surgery with modified frailty index and surgical apgar scores8
Relationship between GLUT-1 and HIF-1α: Is it a friend or foe for studying the biological behaviour of head-and-neck tumorigenesis?8
Tele-screening for early detection of oral cancer during the COVID-19 pandemic era: Diagnostic pitfalls and potential misinterpretations!8
The association of frailty with morbidity and mortality following major mucosal head and neck surgery8
Critical reflections on the clinical implementation of 3D-Printed oral stents for radiotherapy patients8
0.11092495918274